This Billionaire Made $360 Million Selling His Psychedelic Company To Eli Lilly
Twelve years ago, Christian Angermayer took a mushroom trip that inspired him to try to create FDA-approved medicines from psychedelic drugs. Now Big Pharma is making a $2.8 billion bet on his vision.